| PMID | Title | Display |
|---|
| 15379264 | [Distribution of tetracycline-arginine-glycine-aspartate-tyrosine in mice and its effect on bone]. |    |
|
| 16055674 | In vitro evaluation of the angiostatic potential of drugs using an endothelialized tissue-engineered connective tissue. | |
|
| 16181779 | Variolin B and its derivate deoxy-variolin B: new marine natural compounds with cyclin-dependent kinase inhibitor activity. | |
|
| 16207631 | Murine chemokine CXCL2/KC is a surrogate marker for angiogenic activity in the inflammatory granulation tissue. | |
|
| 16397350 | [Bone remodeling and mineral homeostasis]. | |
|
| 16415178 | The microtubule binding drug laulimalide inhibits vascular endothelial growth factor-induced human endothelial cell migration and is synergistic when combined with docetaxel (taxotere). | |
|
| 16423999 | Thymosin beta4 is a determinant of the transformed phenotype and invasiveness of S-adenosylmethionine decarboxylase-transfected fibroblasts. | |
|
| 16428834 | Induction of a ribotoxic stress response that stimulates stress-activated protein kinases by 13-deoxytedanolide, an antitumor marine macrolide. | |
|
| 17183521 | Hyrtiosal, a PTP1B inhibitor from the marine sponge Hyrtios erectus, shows extensive cellular effects on PI3K/AKT activation, glucose transport, and TGFbeta/Smad2 signaling. | |
|
| 17463156 | Peloruside A, an antimitotic agent, specifically decreases tumor necrosis factor-alpha production by lipopolysaccharide-stimulated murine macrophages. | |
|
